Gastrinomas are neuroendocrine neoplasms, usually located in the duodenum or pancreas,
that secrete gastrin and cause a clinical syndrome known as Zollinger-Ellison syndrome …

Gianfranco Delle Fave a Dik J. Kwekkeboom b Erik Van Cutsem c Guido Rindi d Beata Kos-
Kudla e Ulrich Knigge f Hironobu Sasano g Paola Tomassetti h Ramon Salazar i Philippe …

Gastroenteropancreatic (GEP) neoplasms originate from any of the various cell types
belonging to the neuroendocrine system. A general characteristic of GEP endocrine tumours …

Gastric neuroendocrine neoplasms (g-NENs) represent the most frequent digestive NENs
and are increasingly recognized due to expanding indications of upper gastrointestinal …

Duodenal neuroendocrine tumors (NETs) comprise 2–3% of all GI endocrine tumors and are
increasing in frequency. These include gastrinomas, somatostatinomas, nonfunctional …

Neuroendocrine gastroenteropancreatic tumours (GEP-NET) constitute a heterogeneous
group of tumours with their origin in neuroendocrine cells of the embryological gut, most …

Gastrointestinal neuroendocrine tumors (GI-NETs) are rare neoplasms, like all NETs.
However, the incidence of GI-NETS has been increasing in recent years. Gastric NETs (G …

Introduction Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are uncommon but
clinically challenging and fascinating tumors. GEP-NETs present as either functional or as …

AIM: To search for the optimal surgery for gastrinoma and duodenopancreatic
neuroendocrine tumors in patients with multiple endocrine neoplasia type 1. METHODS …

Neuroendocrine gastroenteropancreatic tumors (GEP-NETs) constitute a heterogeneous
group of tumors with their origin in neuroendocrine cells of the embryological gut. Most …